Markedly enhanced levodopa pharmacokinetics from continuous subcutaneous carbidopa administration

被引：0
作者：
Yacoby-Zeevi, O. [1 ]
Oren, S. [1 ]
LeWitt, P. [2 ,3 ]
机构：
[1] NeuroDerm Ltd, Ness Ziona, Israel
[2] Wayne State Univ, Sch Med, Southfield, MI USA
[3] Henry Ford Hosp, Southfield, MI USA
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2010年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：52 / 52
页数：1
相关论文
共 50 条
  • [41] PHARMACOKINETICS OF INHALED LEVODOPA (ADMINISTERED WITH ORAL CARBIDOPA) AND ORAL CARBIDOPA/LEVODOPA IN SUBJECTS WITH PARKINSON'S DISEASE UNDER FED CONDITIONS
    Safirstein, B. E.
    Ellenbogen, A.
    Zhao, P.
    Henney, H. R., III
    Kegler-Ebo, D. M.
    Oh, C.
    PARKINSONISM & RELATED DISORDERS, 2020, 79 : E68 - E68
  • [42] COMT inhibition with tolcapone does not affect carbidopa pharmacokinetics in parkinsonian patients on levodopa/carbidopa (Sinemet®)
    Jorga, KM
    Nicholl, DJ
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1999, 48 (03) : 449 - 452
  • [43] A PHARMACOKINETIC INTERACTION BETWEEN SUBCUTANEOUS APOMORPHINE AND LEVODOPA/CARBIDOPA (SINEMET(R))
    SAMPAIO, C
    BRANCO, MC
    ROSA, MM
    PASSARINHO, M
    CASTROCALDAS, A
    CLINICAL DRUG INVESTIGATION, 1995, 9 (06) : 363 - 366
  • [44] A novel levodopa-carbidopa three-layer gastroretentive tablet for improving levodopa pharmacokinetics
    Zhao, Xiangcheng
    Yan, Peng
    Zhang, Hailong
    Zhou, Wenhu
    Ding, Jinsong
    EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2025, 207
  • [45] Pharmacokinetics of levodopa/benserazide versus levodopa/carbidopa in healthy subjects and patients with Parkinson's disease
    Iwaki, Hirotaka
    Nishikawa, Noriko
    Nagai, Masahiro
    Tsujii, Tomoaki
    Yabe, Hayato
    Kubo, Madoka
    Ieiri, Ichiro
    Nomoto, Masahiro
    NEUROLOGY AND CLINICAL NEUROSCIENCE, 2015, 3 (02): : 68 - 73
  • [46] Pharmacokinetics of Rytary®, An Extended-Release Capsule Formulation of Carbidopa–Levodopa
    Aravind Mittur
    Suneel Gupta
    Nishit B. Modi
    Clinical Pharmacokinetics, 2017, 56 : 999 - 1014
  • [47] Trichophagia affects response to duodenal levodopa/carbidopa gel administration
    Mueller, Thomas
    Haas, Thomas
    Luetge, Sven
    Marg, Marion
    Ehret, Reinhard
    MOVEMENT DISORDERS, 2012, 27 (04) : 588 - 590
  • [48] Jejunal Infusion of Levodopa-Carbidopa Intestinal Gel Versus Oral Administration of Levodopa-Carbidopa Tablets in Japanese Subjects with Advanced Parkinson's Disease: Pharmacokinetics and Pilot Efficacy and Safety
    Othman, Ahmed A.
    Chatamra, Krai
    Mohamed, Mohamed-Eslam F.
    Dutta, Sandeep
    Benesh, Janet
    Yanagawa, Masayoshi
    Nagai, Masahiro
    CLINICAL PHARMACOKINETICS, 2015, 54 (09) : 975 - 984
  • [49] Pharmacokinetics and Pharmacodynamics of Gastroretentive Delivery of Levodopa/Carbidopa in Patients With Parkinson Disease
    Chen, Cuiping
    Cowles, Verne E.
    Sweeney, Michael
    Stolyarov, Igor D.
    Illarioshkin, Sergey N.
    CLINICAL NEUROPHARMACOLOGY, 2012, 35 (02) : 67 - 72
  • [50] Conversion from sustained release carbidopa/levodopa to carbidopa/levodopa/entacapone (Stalevo) in Parkinson disease patients
    Lyons, KE
    Pahwa, R
    CLINICAL NEUROPHARMACOLOGY, 2006, 29 (02) : 73 - 76
12345